Epigenetic alterations, including gene silencing through DNA hypermethylation, have emerged as crucial contributors to breast cancer development and progression [4]; BRCA1 promoter hypermethylation is the most studied epigenetic alteration in malignant breast tumors [5,6,7]. Here, BRCA1 is linked to breast carcinoma.